2 studies found for:    18653228 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed RAD001 in Advanced Sarcoma
Conditions: Soft Tissue Sarcomas;   Bone Sarcomas
Intervention: Drug: RAD001
2 Completed
Has Results
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
Condition: Metastatic Renal Cell Carcinoma
Interventions: Drug: RAD001;   Drug: Placebo

Indicates status has not been verified in more than two years